Search results
Structure Therapeutics Stock Soars on Obesity Pill Data
The Wall Street Journal· 1 day agoShares of Structure Therapeutics jumped more than 45% Monday after a new clinical study boosted...
Structure Therapeutics reports promising weight-loss drug data | Invezz
Invezz· 1 day agoStructure Therapeutics Inc (NASDAQ: GPCR) is up a whopping 80% on Monday after reporting “compelling” topline data for its weight-loss drug. The biopharmaceutical ...
Large, flying, invasive Joro spiders are on their way to NJ. Everything you should know
The Record· 3 hours agoIn November, Dr. David Coyle, entomologist at Clemson University, told NorthJersey.com that the...
Structure Reports Early Oral Weight-Loss Drug Data Adding Allure
Bloomberg· 1 day agoStructure Therapeutics Inc. had its biggest gain ever after reporting data on its experimental oral...
Is Now The Time To Look At Buying Mensch und Maschine Software SE (ETR:MUM)?
Simply Wall St. via Yahoo Finance· 11 hours agoWith a positive outlook on the horizon, it seems like this growth has not yet been fully factored...
Fivetran launches a managed data lake service
TechCrunch· 9 hours agoThe new service aims to remove the repetitive work of managing data lakes by automating and streamlining it for the company clients, freeing them up to...
Data industry boosted by generative AI: Qlik leads the way - SiliconANGLE
SiliconANGLE· 5 hours agoThe data industry is exploding, and generative artificial intelligence is supercharging its growth...
RelationalAI launches powerful Knowledge Graph Coprocessor for Snowflake users
VentureBeat· 3 hours agoDon't miss out on this incredible opportunity to explore various methods for auditing AI models....
Databricks acquires Tabular to build a common data lakehouse standard
TechCrunch· 5 hours agoDatabricks, the analytics and AI giant, has acquired data management company Tabular for an...
Structure patches up holes in share price after GLP-1 linked to 6% weight loss
FierceBiotech· 1 day agoAfter investors frowned on Structure Therapeutics’ oral GLP-1 data in December 2023, the biotech is...